- Home
- YMAB vs MPAA Comparison
YMAB vs MPAA Comparison
Compare YMAB & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- MPAA
- Stock Information
- Founded
- YMAB 2015
- MPAA 1968
- Country
- YMAB United States
- MPAA United States
- Employees
- YMAB N/A
- MPAA N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- MPAA Auto Parts:O.E.M.
- Sector
- YMAB Health Care
- MPAA Consumer Discretionary
- Exchange
- YMAB Nasdaq
- MPAA Nasdaq
- Market Cap
- YMAB 192.4M
- MPAA 188.9M
- IPO Year
- YMAB 2018
- MPAA 1994
- Fundamental
- Price
- YMAB $8.51
- MPAA $11.13
- Analyst Decision
- YMAB Buy
- MPAA
- Analyst Count
- YMAB 11
- MPAA 0
- Target Price
- YMAB $15.02
- MPAA N/A
- AVG Volume (30 Days)
- YMAB 1.3M
- MPAA 124.5K
- Earning Date
- YMAB 08-08-2025
- MPAA 08-11-2025
- Dividend Yield
- YMAB N/A
- MPAA N/A
- EPS Growth
- YMAB N/A
- MPAA N/A
- EPS
- YMAB N/A
- MPAA N/A
- Revenue
- YMAB $88,658,000.00
- MPAA $757,354,000.00
- Revenue This Year
- YMAB N/A
- MPAA $7.74
- Revenue Next Year
- YMAB $15.23
- MPAA $5.00
- P/E Ratio
- YMAB N/A
- MPAA N/A
- Revenue Growth
- YMAB 4.92
- MPAA 5.53
- 52 Week Low
- YMAB $3.55
- MPAA $5.16
- 52 Week High
- YMAB $16.11
- MPAA $12.72
- Technical
- Relative Strength Index (RSI)
- YMAB 81.64
- MPAA 52.28
- Support Level
- YMAB $4.16
- MPAA $9.86
- Resistance Level
- YMAB $8.54
- MPAA $11.74
- Average True Range (ATR)
- YMAB 0.24
- MPAA 0.55
- MACD
- YMAB 0.47
- MPAA -0.04
- Stochastic Oscillator
- YMAB 99.32
- MPAA 60.31
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.